AU2001267177A1 - Diagnosis and treatment of herpes infections - Google Patents

Diagnosis and treatment of herpes infections

Info

Publication number
AU2001267177A1
AU2001267177A1 AU2001267177A AU6717701A AU2001267177A1 AU 2001267177 A1 AU2001267177 A1 AU 2001267177A1 AU 2001267177 A AU2001267177 A AU 2001267177A AU 6717701 A AU6717701 A AU 6717701A AU 2001267177 A1 AU2001267177 A1 AU 2001267177A1
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
herpes infections
herpes
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267177A
Inventor
Faris Farassati
Patrick W. K. Lee
An-Dao Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YANG AN DAO
Original Assignee
YANG AN DAO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YANG AN DAO filed Critical YANG AN DAO
Publication of AU2001267177A1 publication Critical patent/AU2001267177A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001267177A 2000-05-30 2001-05-30 Diagnosis and treatment of herpes infections Abandoned AU2001267177A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20733700P 2000-05-30 2000-05-30
US60/207,337 2000-05-30
PCT/CA2001/000779 WO2001091786A2 (en) 2000-05-30 2001-05-30 Diagnosis and treatment of herpes infections

Publications (1)

Publication Number Publication Date
AU2001267177A1 true AU2001267177A1 (en) 2001-12-11

Family

ID=22770105

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267177A Abandoned AU2001267177A1 (en) 2000-05-30 2001-05-30 Diagnosis and treatment of herpes infections

Country Status (4)

Country Link
US (1) US20010049113A1 (en)
AU (1) AU2001267177A1 (en)
CA (1) CA2410252A1 (en)
WO (1) WO2001091786A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10138912A1 (en) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances
US20100221228A1 (en) * 2006-01-24 2010-09-02 The University Of Chicago y134.5 Deficient HSV and the MAPK Pathway
WO2010134939A2 (en) * 2008-12-19 2010-11-25 Zirus, Inc. Mammalian genes involved in infection
WO2014022185A2 (en) * 2012-08-03 2014-02-06 Albert Einstein College Of Medicine Of Yeshiva University Method to treat or prevent herpesvirus infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9608180D0 (en) * 1996-04-19 1996-06-26 Cancer Res Campaign Tech Phosphate analogues

Also Published As

Publication number Publication date
US20010049113A1 (en) 2001-12-06
WO2001091786A3 (en) 2002-08-08
WO2001091786A2 (en) 2001-12-06
CA2410252A1 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU2001268332A1 (en) Diagnosis and treatment of thalamocortical dysrhythmia
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001281369A1 (en) Cardiac disease treatment and device
AU5788300A (en) Medical treatment method and kit
AU2002225219A1 (en) Diagnosis and treatment of multiple sclerosis
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU2001260834A1 (en) The treatment of herpes
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2002239485A1 (en) Methods for improved diagnosis and treatment of mycobacterial infections
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2281601A (en) Treatment of viral infections using levovirinTM
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
HUP0105310A3 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU3760900A (en) Treatment of menstrual function
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2002323443A1 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU1392601A (en) Prevention and treatment of biomaterial-associated infections